SAIRAH KHADIJA
Allopathic & Osteopathic Physicians|Internal Medicine|Endocrinology, Diabetes & Metabolism GASTONIA, NC NPI 1255828752
Browse related groups: Allopathic & Osteopathic Physicians|Internal Medicine|Endocrinology, Diabetes & Metabolism NC Xeris Pharmaceuticals, Inc. All categories
General Payments — all program years on this page
$158.91
- Category: General Payments
- Program years: PY2021–2023
- Record count: 8
- As of (CMS publication): 2026-01-23
Latest program year (PY2023): $78.26 across 4 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2023) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $78.26 | 4 |
By paying entity
Latest program year (PY2023) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| Xeris Pharmaceuticals, Inc. | $36.92 | 2 |
| Ascendis Pharma Inc | $21.78 | 1 |
| Abbott Laboratories | $19.56 | 1 |
By program year
Records — PY2023 (4)
| Record ID | Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Source |
|---|---|---|---|---|---|---|---|
| 1014549959 | Ascendis Pharma Inc | $21.78 | 06/22/2023 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1018855379 | Abbott Laboratories | $19.56 | 01/06/2023 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1056503435 | Xeris Pharmaceuticals, Inc. | $17.49 | 03/09/2023 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1056503439 | Xeris Pharmaceuticals, Inc. | $19.43 | 12/19/2023 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2023_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.